The global placenta market is experiencing significant growth, with projections indicating an increase from USD 652.21 million in 2025 to approximately USD 1,404.87 million by 2034, reflecting a compound annual growth rate (CAGR) of 8.9% during the forecast period.
Market Overview
Placental-derived products have gained prominence across various industries due to their rich composition of bioactive compounds, including growth factors, hormones, and proteins. These components contribute to the therapeutic and cosmetic benefits of placenta-based products, leading to increased adoption in pharmaceuticals, cosmetics, and nutraceuticals.
Market Segmentation
By Type:
- Porcine Placenta: Derived from pigs, porcine placenta is rich in growth factors and proteins, making it highly valued in both pharmaceuticals and cosmetics. Its regenerative properties are utilized in skin regeneration and anti-aging products.
- Equine Placenta: Sourced from horses, equine placenta is primarily used in premium cosmetic products and therapeutic treatments. It is appreciated for its high levels of growth factors and amino acids that enhance skin rejuvenation and repair.
- Ovine Placenta: Obtained from sheep, ovine placenta is utilized in various applications due to its beneficial properties.
By Application:
- Pharmaceuticals: Placental extracts are explored for their therapeutic properties, including liver function improvement and treatment of menopausal symptoms.
- Cosmetics: The anti-aging and skin rejuvenation properties of placenta extracts have led to their incorporation in skincare products.
- Nutraceuticals: Placenta-based supplements are gaining popularity for their potential health benefits.
Country-wise Market Trends
United States
The United States placenta market is experiencing steady growth, driven by advanced maternal healthcare infrastructure, early adoption of biomarker-based diagnostics, and robust clinical research support. The market is expected to expand at a CAGR of around 6.8% from 2025 to 2035.
United Kingdom
The UK's placenta market is estimated to grow at a CAGR of approximately 6.5% from 2025 to 2035. The National Health Service (NHS) could greatly influence demand by introducing placental biomarkers into its antenatal screening protocols.
South Korea
South Korea's placenta market is expected to expand at a CAGR of 6.7% from 2025 to 2035. The country's rapidly aging maternal population and rising incidence of gestational hypertension create a strong case for placental growth factor test adoption.
Brazil
The Brazil placenta market is projected to exhibit a growth rate (CAGR) of 9.2% during 2025-2033. The market is experiencing significant growth due to the increasing demand for placenta-based products in the cosmetics industry, continual advancements in research and development (RD) activities, and the growing popularity of natural health solutions.
Conclusion
The global placenta market is poised for substantial growth, driven by increasing demand across pharmaceuticals, cosmetics, and nutraceuticals. Advancements in research and development, coupled with rising consumer awareness of the benefits of placenta-derived products, are expected to further propel market expansion in the coming years.
More Trending Latest Reports By Polaris Market Research:
Warehouse Automation Market - update
U.S. Industrial Microwave Heating Market
Distributed Antenna System (DAS) Market
